Bharat Biotech Ocugen Inc US

Emergency use authorization request filed with FDA for paediatric use of Bharat Biotech's Covaxin

The submission is based on the results of a Phase 2/3 paediatric clinical trial conducted by Bharat Biotech in India with 526 children 2-18 years of age.

published on : 5th November 2021